Are all COX-2 inhibitors created equal?

被引：10
|
作者：
Chang, IJ [1 ]
Harris, RC [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Div Nephrol, Nashville, TN 37232 USA
来源：
HYPERTENSION | 2005年 / 45卷 / 02期
关键词：
D O I：
10.1161/01.HYP.0000153049.77150.d7
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：178 / 180
页数：3
相关论文
共 50 条
  • [31] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
    Debabrata Mukherjee
    Eric J Topol
    Arthritis Res Ther, 5
  • [32] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Luo, C
    He, ML
    Bohlin, L
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (08) : 926 - 933
  • [33] COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors
    Whittle, BJR
    GUT, 2000, 47 (03) : 320 - 325
  • [34] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Cheng Luo
    Ming-liang He
    Lars Bohlin
    Acta Pharmacologica Sinica, 2005, 26 : 926 - 933
  • [35] Cox-2 selective inhibitors induce apoptosis by both cox-2 dependent and cox-2 independent mechanisms.
    Agarwal, B
    Swaroop, P
    Protiva, P
    Chuttani, R
    Ramey, WG
    Holt, PR
    GASTROENTEROLOGY, 2000, 118 (04) : A52 - A52
  • [36] Glycosylation of cyclooxygenase-2 (COX-2) influences effectiveness of COX-2 inhibitors
    Graham, Kamara Whitney
    Sevigny, Mary B.
    Gabriel, Bianca S.
    FASEB JOURNAL, 2009, 23
  • [37] COX-2 inhibitors and gastrointestinal toxicity
    Bombardier, C
    Laine, L
    Reicin, A
    Shapiro, D
    Burgos-Vargas, R
    Davis, B
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 164 (08) : 1200 - 1200
  • [38] COX-2 inhibitors off the hook?
    Dorey, E
    CHEMISTRY & INDUSTRY, 2005, (05) : 5 - 5
  • [39] COX-2 inhibitors with a methylsulfoxide pharmacophore
    Chung, S
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (05) : 617 - 620
  • [40] COX-2 selective inhibitors and bone
    Goodman, SB
    Ma, T
    Genovese, M
    Smith, RL
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (03): : 201 - 205
12345